The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells.

Saved in:
Bibliographic Details
Title: The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells.
Authors: Lewis MI; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Pulmonary/Critical Care Division, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: Michael.Lewis@cshs.org., Shapiro S; Division of Cardiology, VA Greater Los Angeles Healthcare System and Division of Pulmonary/Critical Care, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA., Oudiz RJ; Division of Cardiology, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA., Nakamura M; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Geft D; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Matusov Y; Pulmonary/Critical Care Division, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Hage A; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Tapson VF; Pulmonary/Critical Care Division, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Henry TD; The Carl and Edyth Lindner Center for Research and Education and Interventional Cardiology, The Christ Hospital, Cincinnati, OH, USA., Azizad P; Pulmonary/Critical Care Division, Kaiser Sunset Medical Center, Los Angeles, CA, USA., Saggar R; Pulmonary/Critical Care Division, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA., Mirocha J; Biostatistics and Cancer Institute Shared Services, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Karpov OA; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Van Eyk JE; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Marbán E; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Source: EBioMedicine [EBioMedicine] 2024 Feb; Vol. 100, pp. 104900. Date of Electronic Publication: 2023 Dec 12.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-3964
DOI:10.1016/j.ebiom.2023.104900